Search
for
Sort by
Research 31–60 of 1000+
- Risk of hair loss with different antidepressants
- Beneath the surface: dermatology and psychiatry
- Sustain Released Bupropion in the Treatment of Tricotillomania: Outpatient Follow Up Survey
- How to Select Pharmacologic Treatments to Manage Recidivism Risk in Sex Offenders: Consider Patient Factors When Choosing Off-Label Hormonal and Nonhormonal Agents
- Trichotillomania in long COVID successfully treated with escitalopram: A case report
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- Citalopram–induced delusions in an older adult
- Hair Loss Associated with Sertraline: Two Case Reports and Review
- Alleviation of alopecia after switching from escitalopram to duloxetine: a case report
- Trichotillomania in Childhood: A Case Report
- Trichotillomania Across Circuits: Neurobiology, Sensory Processing, and Genetic Insights
- Hair-Related Dysmorphophobia: A Mini-Review
- Trichodaganomania: A Curious Habit
- Insights into the peripheral nature of persistent sexual dysfunction associated with post-finasteride, post-SSRI and post-accutane syndromes: lessons learned from a case study
- Trichotillomania with Giant Gastric Trichobezoar in a Female Child: A Case Report
- TRICHOTILLOMANIA WITH GIANT GASTRIC TRICHOBEZOAR IN A FEMALE CHILD: A CASE REPORT
- Hair-Pulling Disorder
- Letters to the Editors
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- Antidepressants have Anti-inflammatory Effects that may be Relevant to Dermatology: A Systematic Review
- Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances
- O "25 de Abril" como ruptura sociobiográfica: potenciaçoes e refracçoes no campo cultural
- Unconventional side effects of antidepressants: Focus on emotional blunting
- A Review of the Role of Psychiatrists and Pediatricians in Outpatient Treatment of Adolescents with Anorexia and Bulimia Nervosa
- Managing the adverse effects of cytotoxic chemotherapy at the level of primary healthcare
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases
- Intraoperative Iris Behavior during Phacoemulsification Maneuvers in Rabbits Treated with Selective α1-Blocker, 5α-Reductase Inhibitor, or Anxiolytic Medication
- Relating neurosteroid modulation of inhibitory neurotransmission to behaviour
- Antiandrogens and Androgen Inhibitors
- A New Look at the 5?-Reductase Inhibitor Finasteride